NCT06118918

Brief Summary

this study aims to investigate the effect of the cardiac rehabilitation program on perceived health, status, anxiety, depression, and 90-day readmission rates for post-cardiac surgery patients. The participants in this study will be randomly allocated to either an experimental or control group, the experimental group will receive the cardiac rehabilitation programThe cardiac rehabilitation program extends over 3 months after cardiac surgery. The program includes exercise, health education, and stress management. All content will delivered to the participants through the WhatsApp application as instruction videos and short lectures. exercise will be gradually increased in terms of intensity, and duration. Health education will cover topics like a healthy diet blood pressure, blood cholesterol control, smoking cessation..etc. Stress management will include relaxation therapy, breathing control, behavioral change, and other strategies to control stress. All interventions are guided by universal guidelines like the Australian Cardiovascular Health and Rehabilitation Association (ACRA) and American Heart Association (AHA)..All potential participants will be assessed before being involved in the study. assessment including a general physical examination, inspection of the surgical site, and recent history for potential patient symptoms after discharge, such as chest pain, palpitation, fatigue, or dyspnea. The assessment includes electrocardiograph (ECG), blood samples, and echocardiography analyses. Based on the findings of this assessment, patients will be classified by the cardiologist as either grade I, II, III, or IV, according to the New York Heart Association (NYHA) Classification. Patients who will be eligible to participate in the present study should be grade I or II in the NYHA Classification for dyspnea. Participants in the control group will receive the usual care (general instructions and advice from physicians and nurses). All materials will be delivered to all participants after completing the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

November 3, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 7, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

August 1, 2024

Status Verified

July 1, 2024

Enrollment Period

9 months

First QC Date

October 31, 2023

Last Update Submit

July 31, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Perceived health status

    Short form-36 health survey will be used to measure the perceived health status.. The score ranges from 0 to 100. A high score defines a more favorable health state.

    At base-line, after 12 weeks , and 1 month later

  • Anxiety level

    Anxiety will be measured using the Hospital Anxiety and depression scale(HADS). The score ranges from 0 to 21. The highest score indicates worse symptoms.

    At base-line, after 12 weeks, and 1 month later

  • Depression

    Depression will be measured using the Hospital anxiety and depression scale(HADS). The score ranged from 0 to 21. The highest score indicates worse symptoms.

    At base-line, after 12 weeks , and 1 month later

  • 90-day readmission rate

    readmission rate will measured by reviewing patient medical record

    after90 days

Study Arms (2)

The interventional arm (participants who will received the cardiac rehabilitation program

EXPERIMENTAL

this arm will receive the cardiac rehabilitation program after completing the cardiac surgery and being assessed for eligibility.

Behavioral: Phase II comprehensive cardiac rehabilitation program

the control arm (who will receive the usual care)

NO INTERVENTION

the control group will receive the usual care ( the usual instruction and general advice from the physicians and the nurses)

Interventions

the program extends over 3 months after cardiac surgery. The program includes exercise, health education, and stress management. all content will be delivered to the participants through the WhatsApp application as instruction videos and short lectures. exercise will be gradually increased in terms of intensity, and duration. health education will cover topics like a healthy diet blood pressure, blood cholesterol control, smoking cessation …etc. stress management will include relaxation therapy, breathing control, behavioral change, and other strategies to control stress. Phone call follow-ups once weekly will be made by one of the research team to evaluate the adherence and answer potential questions All interventions are guided by universal guidelines like the Australian Cardiovascular Health and Rehabilitation Association (ACRA) and American Heart Association (AHA

The interventional arm (participants who will received the cardiac rehabilitation program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged over 18 years.
  • underwent cardiac surgery.
  • classified as grade I or II according to NYHA classification of dyspnea by the physician.
  • does not complain of any physical or mental condition preventing him or her from participating.
  • agree to participate in the study.

You may not qualify if:

  • aged under 18 years.
  • classified as grade III or IV according to NYHA classification of dyspnea by the physician.
  • complain of any physical or mental condition preventing him or her from participating.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prince Hamzah hospital

Amman, 11946, Jordan

Location

MeSH Terms

Conditions

Anxiety DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • ALI SU HARBI

    University Putra Malaysia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 31, 2023

First Posted

November 7, 2023

Study Start

November 3, 2023

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

August 1, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

No plan to share IPD

Locations